Hospital Service Volume as an Indicator of Treatment Patterns for Colorectal Cancer

被引:0
|
作者
Lizalek, Jason M. [1 ]
Eske, Jamie [2 ]
Thomas, Katryna K. [3 ]
Reames, Bradley N. [1 ]
Smith, Lynette [1 ,2 ]
Schmid, Kendra [2 ]
Krell, Robert W. [3 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA
[3] Brooke Army Med Ctr, Dept Surg, Ft Sam Houston, TX USA
关键词
Colon cancer; Overtreatment; Service volume; Undertreatment;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: A hospital's approach (volume of cancer treatment services provided) to treating metastatic colorectal cancer influences a patient's treatment as strongly as patient disease status. The implications of hospital-level treatment approaches across disease stages remain understudied. We sought to determine if hospital service volume (SV) for metastatic colorectal cancer could be predictive of nonstandard treatment patterns in stages I-III colon cancer. Materials and methods: Using the National Cancer Database, we examined rates of nonstandard treatment patterns among patients with colon cancer between 2010 and 2017. After adjusting for clinicopathological characteristics using multivariable logistic regression, we evaluated the relationship between hospital-level SV for metastatic colorectal cancer and nonstandard treatment approaches for patients with stages I-III colon cancer. Results: There were significant associations between hospital-level SV for metastatic colorectal cancer and the odds of chemotherapy overtreatment among patients with stage I-III colon cancer, as well as undertreatment among patients with stages II-III disease after adjusting for hospital-, patient-, and tumor-level covariates. Patients at the highest-level SV hospitals for metastatic disease had 1.29 higher odds (95% CI = 1.18-1.41; P <0.0001) of receiving overtreatment compared to patients from lowest SV hospitals. The odds ratio of undertreatment in highest SV compared to lowest SV was 0.64 (95% CI 0.560.72; P < 0.0001). Conclusions: Hospital-level SV of patients with metastatic colon cancer is a significant indicator of nonstandard treatment patterns among patients with stage I-III colon cancer. Hospitals with the highest volume of cancer treatments have higher odds of providing overtreatment, while low SVs are associated with higher odds of undertreatment. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:685 / 696
页数:12
相关论文
共 50 条
  • [31] Metastatic colorectal cancer (mCRC) treatment patterns in the Medicare population
    Snider, Jeremy
    Wang, Ed
    Anderson, Sibyl
    Steelquist, Jordan
    Warnick, Greg S.
    Fedorenko, Catherine R.
    Shankaran, Veena
    Ramsey, Scott David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [32] Patterns of metachronous metastases after curative treatment of colorectal cancer
    van Gestel, Yvette R. B. M.
    de Hingh, Ignace H. J. T.
    van Herk-Sukel, Myrthe P. P.
    van Erning, Felice N.
    Beerepoot, Laurens V.
    Wijsman, Jan H.
    Slooter, Gerrit D.
    Rutten, Harm J. T.
    Creemers, Geert-Jan M.
    Lemmens, Valery E. P. P.
    CANCER EPIDEMIOLOGY, 2014, 38 (04) : 448 - 454
  • [33] Patterns of metachronous metastases after curative treatment of colorectal cancer
    Van Gestel, Y. R. B. M.
    De Hingh, I. H. J. T.
    Van Herk-Sukel, M. P. P.
    Van Erning, F. N.
    Beerepoot, L.
    Wijsman, J. H.
    Slooter, G. D.
    Rutten, H. J. T.
    Creemers, G. J. M.
    Lemmens, V. E. P. P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S513 - S513
  • [34] The influence of socioeconomic aspects and hospital case volume on survival in colorectal cancer in Saxony, Germany
    Bogner, Andreas
    Weitz, Juergen
    Piontek, Daniela
    BMC CANCER, 2023, 23 (01)
  • [35] The influence of socioeconomic aspects and hospital case volume on survival in colorectal cancer in Saxony, Germany
    Andreas Bogner
    Jürgen Weitz
    Daniela Piontek
    BMC Cancer, 23
  • [36] The hospital costs for diagnosis and treatment of colorectal cancer (Colon-CA)
    Lee, JG
    Vigil, HT
    Leung, JW
    GASTROINTESTINAL ENDOSCOPY, 1999, 49 (04) : AB145 - AB145
  • [37] Hospital Treatment Intensity for Metastatic Colorectal Cancer: A Predictor of Improved Survival
    Adams, Alexandra M.
    Carpenter, Elizabeth M.
    Thomas, Katryna M.
    Nelson, Daniel W.
    Krell, Robert W.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S244 - S244
  • [38] Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants
    Fleming, Steven T.
    Mackley, Heath B.
    Camacho, Fabian
    Yao, Nengliang
    Gusani, Niraj J.
    Seiber, Eric E.
    Matthews, Stephen A.
    Yang, Tse-Chuan
    Hwang, Wenke
    JOURNAL OF RURAL HEALTH, 2016, 32 (02): : 113 - 124
  • [39] Tooth agenesis: A susceptible indicator for colorectal cancer?
    Paranjyothi, M. V.
    Kumaraswamy, K. L.
    Begum, Lubna Firdose
    Manjunath, K.
    Litha
    Basheer, Shaini
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (03) : 527 - 531
  • [40] Treatment Patterns and Outcomes for Colorectal Cancer Spine Metastases Treated with SRS
    Klebaner, D.
    Jaoude, J. A.
    Pratapneni, A.
    Chang, S. D.
    Gibbs, I. C.
    Kollipara, T.
    Kumar, K. A., Jr.
    Rahimy, E.
    Park, D.
    Fujimoto, D. K.
    Mendoza, M.
    Persad, A.
    Soltys, S. G.
    Pollom, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E244 - E245